xRead - Olfactory Disorders (September 2023)

20426984, 2022, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22929, Wiley Online Library on [04/09/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

330

INTERNATIONAL CONSENSUS ON OLFACTION

BED Binge Easting Disorder bFGF basic fibroblast growth factor BICAMS The Brief International Cognitive Assessment for MS BMI Body Mass Index BMS burning mouth syndrome BNT Boston Naming Test BOLD Blood oxygen level-dependent sig nal BOMCT Blessed Orientation Memory Con centration Test BPD Bipolar Disorder BSG basigin B-SIT R Brief Smell Identification Test (also known as the Cross-Cultural Smell Identification Test or CC-SIT) BTT Butanol threshold test BVMT Brief Visuospatial Memory Test CA Congenital anosmia CAMCOG Cambridge Examination for Men tal Disorders in the Elderly cAMP cyclic adenosine monophosphate CASI Cognitive Abilities Screening Instrument CCCRC Connecticut Clinical Chemosen sory Research Center test CFD computational fluid dynamics cGMP cyclic guanine monophosphate ChE Cholinesterase CHH congenital hypogonatropic hypog onadism CI Cognitive impairment CLC Charcot Leyden crystal protein CN I Cranial nerve one CNS Central Nervous System COT Classic olfactory training COMB Combination COVID-19 coronavirus disease 2019 COWAT Controlled Oral Word Association Test CPG Clinical Practice Guideline CR Chronic Rhinitis CRP C-reactive protein CRS Chronic rhinosinusitis CRSsNP Chronic rhinosinusitis without nasal polyps CRSwNP Chronic rhinosinusitis with nasal polyps CCL chemokine ligand CCR chemokine receptor CD Cognitive decline CDKN2A/P16INK4a Cyclin-dependent kinase inhibitor 2A/P16

CSF Cerebrospinal fluid CSIT 40-item Chinese Smell Identifica tionTest CSQ Chemosensory questionnaire CT Computerized tomography CVLT II California Verbal Learning Test-II CXCL chemokine (C-X-C motif) ligand D CFL: Category Fluency: Discrimi nation DIP Drug-induced Parkinsonism DLB Dementia with Lewy bodies DM Diabetes mellitus DMT disease-modifying therapy DODT Disseldorf Odour Discrimination Test DRS Dementia Rating Scale DT Detection threshold DTI Diffusion tensor imaging EBM Evidence Based Medicine EBR Evidence Based Review EBRR Evidence Based Review with Rec ommendations ECP Eosinophilic cationic protein EDSS Expanded Disability Status Scale EEA Endoscopic endonasal approach EHLS Epidemiology of Hearing Loss Study EMBASE Excerpta Medica database EO-PD Early-onset PD EOG Electro-olfactogram ERP Event-related potential ETTH Episodic tension type headache ESS Endoscopic sinus surgery F Female FA Fractional Anisotropy FAB Frontal Assessment Battery FDA Federal Drug Administration FDG 18 F-2-fluoro-2-deoxy-D-glucose FFQ Food-Frequency Questionnaire FG Fusiform gyrus FH Family history fMRI Functional magnetic resonance imaging FP Fluticasone propionate FTD Frontotemporal dementia FTG Fusiform gyrus FTG-PET Positron emission tomography using the radiopharmaceutical fluorodeoxyglucose GAD-7 Generalized Anxiety Disorder DAT Dopamine transporter DHA docosahexanoic acid DISC Discrimination